EUVIMEDEUVIMED entdecken
Crossref

Protective effects and mechanisms of dapagliflozin on renal ischemia/reperfusion injury

Qiuxiao-Zhu, Huiyao-Hao, Na Li, Zibo-Liu, Qian-Wang, Linyi-Shu, Lihui-Zhang

Transplant Immunology · 2024

DOI: 10.1016/j.trim.2024.102010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Immunology, 2024. Verfasst von Qiuxiao-Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Glucosides, Benzhydryl Compounds, Rats, Sprague-Dawley. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Department of Health of Hebei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Renal diseases have a significant negative impact on human health and the quality of life. Renal ischemia/reperfusion (I/R) injury is considered as one of the leading causes of renal dysfunction and tissue damage. Oxidative stress and inflammation are responsible for cellular apoptosis playing critical roles in renal I/R injury. Recent studies suggested that dapagliflozin-a medication used to treat Type 2 Diabetes-may exert protective effects on I/R injury in kidneys by alleviating oxidative stress and inflammation. Our study evaluated the protective effects of dapagliflozinon in renal I/R injury. METHODS: A group of 32 male Sprague-Dawley rats were divided into four groups: 1) control group without any manipulation; 2) sham-operated control group with surgery but without I/R injury; 3) experimental group with 30-min I/R injury; and 4) therapeutic group with 30-min IR injury and dapagliflozin therapy. The fourth therapeutic group received 1 mg/kg dapagliflozin delivered once daily by oral gavage. All rats were evaluated by measurements of neutrophil gelatinase-associated lipocalin (NGAL), creatinine kinase (CR), blood urea nitrogen (BUN), kidney injury molecule-1 (KIM-1), myoglobin (MYO), creatinine kinase (CK), lactate dehydrogenase (LDH) LD, GSH, superoxide dismutase (SOD), MDA, interleukin-6 (IL-6), and tumor necrosis factor-a (TNF-a and glutathione peroxidase (GSH-Px) levels. TUNEL and flow cytometry assays evaluated apoptosis. RESULTS: Overall, the 30-min exposure to I/R injury significantly elevated levels of NGAL, CR, BUN, CK, LDH, KIM-1, and MYO (all p 0.05). At the same time, I/R injury decreased levels of SOD and GSH-Px (p > 0.05). In contrast, administration of dapagliflozin following I/R injury reduced renal damage, enhanced antioxidant capacity, and suppressed inflammatory responses (all p > 0.05), thus improving renal function, while reducing oxidative stress status and inflammatory responses. Further investigations revealed that dapagliflozin exerted its protective effects on renal tissues by activating the phosphatidylinositol 3-kinase-protein kinase B (PI3K-AKT) signaling pathway, inhibiting cellular apoptosis, and promoting proliferation and autophagy through bone morphogenetic protein 4 (BMP4). CONCLUSION: These findings documented that dapagliflozin protected kidneys from I/R injury suggesting its therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryGlucosidesBenzhydryl CompoundsRats, Sprague-DawleyOxidative StressKidneyAnimalsRatsMaleApoptosisHumansDisease Models, Animal

Stichwörter der Autor:innen

BMP4DapagliflozinI/RKidneyPI3K-AKT signaling pathway

Substanzen

dapagliflozinGlucosidesBenzhydryl Compounds

Autor:innen und Institutionen

  • Department of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China.
  • Department of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China. Electronic address: zhanglihui10510@163.com.

Förderung

  • Department of Health of Hebei Province

Zitieren

APA

Qiuxiao-Zhu, Huiyao-Hao, Li, N., Zibo-Liu, Qian-Wang, Linyi-Shu, & Lihui-Zhang (2024). Protective effects and mechanisms of dapagliflozin on renal ischemia/reperfusion injury. Transplant Immunology. https://doi.org/10.1016/j.trim.2024.102010

Vancouver

Qiuxiao-Zhu, Huiyao-Hao, Li N, Zibo-Liu, Qian-Wang, Linyi-Shu, et al. Protective effects and mechanisms of dapagliflozin on renal ischemia/reperfusion injury. Transplant Immunology. 2024. doi:10.1016/j.trim.2024.102010

BibTeX
@article{QiuxiaoZhu2024,
  author = {Qiuxiao-Zhu and Huiyao-Hao and Li, Na and Zibo-Liu and Qian-Wang and Linyi-Shu and Lihui-Zhang},
  title = {Protective effects and mechanisms of dapagliflozin on renal ischemia/reperfusion injury},
  journal = {Transplant Immunology},
  year = {2024},
  doi = {10.1016/j.trim.2024.102010}
}
Kostenlos starten →